Tasso Inc.
This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders. This investigation will include a minimum of 40 sample sets from unique patients.
This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders. This investigation will include a minimum of 40 sample sets from unique patients. The primary aim of this study is to demonstrate the agreement between capillary blood collected using the Tasso device and venous blood collected in a K2EDTA (dipotassium ethylenediaminetetraacetic acid) tube according to established sampling procedures for quantification of WBC and ANC as part of a standard…
Inclusion Criteria: 1. Willing and able to provide written (or electronic) informed consent prior to study entry 2. At least 18 years of age 3. Requiring a CBC blood test as part of the patient's standard of care 4. Have abnormal laboratory results of either leukopenia, leukocytosis or neutropenia. 5. Normal skin integrity and healthy skin appearance around the capillary collection site (upper arm/shoulder area on at least one side) Exclusion Criteria: 1. Unable to give full and free consent to participate in a study due to limited capacity or risk of undue influence or coercion (including…
Novel blood collection device
Arctuva estimate
Verify or correct the compensation shown for this listing.